Zhao Rong, Liu Haibing
Department of Otolaryngology, the Central Hospital of Chengdu Railway, Chengdu, 610081, China.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011 Aug;25(15):690-1.
To investigate the diagnosis and treatment of laryngopharyngeal reflux disease.
Patients suspect of laryngopharyngeal reflux disease in our out-patient department from Jan 2008 to Jan 2009 were included in this study. All patients were assessed using the reflux symptom index(RSI) and the reflux finding score(RFS). The positive criteria of RSI was score > 13 and that of RFS was score > 7. Fifty-eight double positive patients accepted omeprazole oral administration. After continuous oral administration for three months, all patients received RSI and RFS assessment again.
After treatment, the symptoms of 41 patients were significantly alleviated. In addition, RSI were positive in 41 cases and RFS were positive in 37 cases. Thirty-seven cases were double positive.
The RSI and RFS could serve as an effective assessment method and could accurately document treatment efficacy in patients with LPR. Proton pump inhibitor such as omeprazole is an effective treatment for patients with LPR.
探讨喉咽反流病的诊断与治疗。
纳入2008年1月至2009年1月在我院门诊怀疑患有喉咽反流病的患者。所有患者均采用反流症状指数（RSI）和反流发现评分（RFS）进行评估。RSI的阳性标准为评分>13，RFS的阳性标准为评分>7。58例双阳性患者接受奥美拉唑口服治疗。连续口服三个月后，所有患者再次接受RSI和RFS评估。
治疗后，41例患者症状明显缓解。此外，RSI阳性41例，RFS阳性37例。双阳性37例。
RSI和RFS可作为一种有效的评估方法，能准确记录LPR患者的治疗效果。质子泵抑制剂如奥美拉唑是治疗LPR患者的有效药物。
